CareRx Corporation reported earnings results for the third quarter and nine months ended September 30, 2022. For the third quarter, the company reported sales was CAD 97.35 million compared to CAD 71.27 million a year ago. Net loss was CAD 1.78 million compared to CAD 3.93 million a year ago. Basic loss per share from continuing operations was CAD 0.04 compared to CAD 0.11 a year ago.
For the nine months, sales was CAD 287.41 million compared to CAD 165.78 million a year ago. Net loss was CAD 29.67 million compared to CAD 18.28 million a year ago. Basic loss per share from continuing operations was CAD 0.63 compared to CAD 0.58 a year ago.